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Tamoxifen-like metallocifens target thioredoxin system determining 
mitochondrial impairment leading to apoptosis in Jurkat cells 
Valeria Scalcon,a* Michèle Salmain,b* Alessandra Folda,a Siden Top,b Pascal Pigeon,b,c Hui Zhi Shirley 
Lee,b,c Gérard Jaouen,b,c Alberto Bindoli,d Anne Vessières,b**and Maria Pia Rigobelloa** 
Abstract 
Tamoxifen-like metallocifens (TLMs) of the group-8 metals (Fe, Ru, Os) show strong anti-proliferative activity on cancer cell 
lines resistant to apoptosis, owing to their unique redox properties. On the other hand, the thioredoxin system, which is 
involved in cellular redox balance, is often overexpressed in cancer cells, especially in tumour types resistant to standard 
chemotherapies. Therefore, we investigated the effect of these three TLMs on the thioredoxin system and evaluated the 
input of the metallocene unit by comparison with structurally related organic tamoxifens. In vitro, all three TLMs became 
strong inhibitors of the cytosolic (TrxR1) and mitochondrial (TrxR2) isoforms of thioredoxin reductase and after enzymatic 
oxidation with HRP/H2O2 while none of the organic analogues was effective. In Jurkat cells, TLMs inhibited mainly TrxR2, 
resulting in accumulation of oxidized thioredoxin 2 and cell redox imbalance. Overproduction of ROS ensued in a strong 
decrease of mitochondrial membrane potential, translocation of cytochrome c to the cytosol and activation of caspase 3, 
thus leading to apoptosis. None of these events occurred with organic tamoxifens. The mitochondrial fraction of cells 
exposed to TLMs contained a high amount of the corresponding metal as quantified by ICP-OES. The lipophilic and cationic 
character associated with the singular redox properties of the TLMs could explain why they alter the mitochondrial function. 
These results provide new insights into the mechanism of action of tamoxifen-like metallocifens, underlying their prodrug 
behaviour and the pivotal role played by the metallocenic entity in their cytotoxic activity associated with induction of 
apoptosis. 
Significance to Metallomics 
Biological effects of tamoxifen-like metallocifens (TLMs) of iron, ruthenium and osmium on Jurkat cells were compared to those of the corresponding organic 
tamoxifens. All three TLMs behaved as strong inhibitors of mitochondrial thioredoxin reductase both in vitro and in Jurkat cells, induced mitochondrial 
membrane depolarization and eventually cell apoptosis. The organic molecules were inactive in this set of experiments thus underlying the role of the metals. 
These effects are associated to the unique redox properties of the metallocene units and charge-driven accumulation of TLMs in mitochondria. Among the 
three compounds, the ferrocenyl TLM appears as the most active. 
 
Introduction 
Breast cancer remains the most common malignancy in women, and 
despite the efforts that have been put on its early detection half a 
million people died from this disease in 2012.1 Early breast cancer is 
now considered potentially curable and tamoxifen administration is 
the standard endocrine therapy of hormone receptor positive breast 
cancer. This is not the case for metastatic breast cancers, which are 
heterogeneous, often resistant to apoptosis and consequently 
difficult to cure. Thus, the search for new drugs, with mechanisms of 
action different from those already in use are urgently needed. Some 
of us introduced sometime ago ferrocenyl analogues of OH-
tamoxifen (OH-Tam[2], chart 1), an active metabolite of tamoxifen.2, 
3 Not only these compounds kept an anti-oestrogenic effect on 
hormone-dependent breast cancer cells but they also displayed a 
high cytotoxicity on the triple negative breast cell line MDA-MB-231 
(IC50 = 0.5 µM for Fc-OH-Tam)3 as well as on a panel of cells resistant 
to apoptosis (glioma, melanoma).4,5 In addition, Fc-OH-Tam 
significantly inhibited in vivo growth of MDA-MB-231 xenografted 
tumours in mice when formulated in lipid nanocapsules (LNC).4 
Regarding the mechanism of action of this complex, we found that 
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Fc-OH-Tam induced strong senescence in MDA-MB-231 as compared 
to low apoptosis.6 These remarkable properties have been linked to 
the presence of the [Fc-ene-phenol] motif that is selectively 
activated in cancer cells, therefore revealing their redox 
environment.7 As such Fc-OH-Tam acts as a prodrug whose 
cytotoxicity is associated to its oxidation to a highly electrophilic 
quinone methide.7 More recently we found that the quinone 
methide of Fc-OH-Tam was able to strongly inhibit the enzyme 
thioredoxin reductase (TrxR) in vitro.8 TrxR belongs to the 
thioredoxin system that is responsible for thiol redox homeostasis 
together with the glutathione system. It is present as cytosolic 
(TrxR1) and mitochondrial (TrxR2) isoforms, both displaying a 
selenocysteine residue at their C-terminal active site, which acts as a 
major target of electrophiles as well as many metal complexes.9-12 
TrxR is often overexpressed in cancer cells and its inhibition may lead 
to cell apoptosis.13,14 Fc-OH-Tam inhibits TrxR in Jurkat cells, 
indicating that its conversion to quinone methide occurs in cellulo via 
endogenous oxidizing systems. Recent studies on the tamoxifen-like 
complex of osmium (Oc-OH-Tam, chart 1) showed that in vitro 
inhibition of TrxR only occurred after its enzymatic oxidation by the 
HRP/H2O2 mixture. Although less cytotoxic than Fc-OH-Tam on MDA-
MB-231 cell line (IC50 = 2.7 µM)15, Oc-OH-Tam proved to be an 
effective inhibitor of TrxR in Jurkat cells inducing mitochondrial 
dysfunction and cell death.16  
In order to get a better insight into the mechanism of action of 
tamoxifen-like metallocifens (TLMs) and to evaluate the role played 
by the metallocenic unit we report here the comparison of some 
biological effects of TLMs of iron, ruthenium and osmium with those 
of their organic tamoxifen analogues (Chart 1). Experiments included 
in vitro studies on purified cytosolic and mitochondrial isoforms of 
TrxR (TrxR1 and TrxR2) followed by studies on mitochondrial 
functionality in Jurkat cells. In particular, the redox state of 
mitochondrial Trx, ROS level and mitochondrial membrane potential 
(MMP) were measured. In addition, the intracellular distribution of 
metals was determined by ICP-OES measurements. On the whole, 
only TLMs and not their organic analogues were able to initiate cell 
apoptosis via mitochondria-mediated pathway.  
 
Chart 1 : Formulae of the compounds under study 
 
Experimental 
Materials 
Stock solutions of the compounds (1 x 10-2 M) were prepared in 
DMSO and were stable for at least two months if kept at 4 °C. 
Horseradish peroxidase (HRP), yeast glutathione reductase, Tam, 
and OH-Tam[2], iodoacetamide (IAM), iodoacetic acid (IAA), DTNB 
and metal standards were purchased from Sigma Aldrich (Saint Louis, 
MO, USA). BIAM, TMRM, DHR and MitoSOX were purchased from 
Invitrogen (Thermo Fisher Scientific, Waltham, MA, USA). Primary 
antibodies utilized: Trx2 monoclonal antibody (H75) and caspase-3 
polyclonal antibody clone H-277 (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA); cytochrome c clone 7H8.C12 (BioSource 
International, Inc., Camarillo, CA, USA); anti-cytochrome c oxidase 
subunit 4 monoclonal antibody 1D6 (Thermo Fisher Scientific, 
Waltham, MA, USA). 
Enzymatic oxidation of the compounds by the HRP/H2O2 mixture 
Enzymatic oxidation of the compounds (25 - 50 µM) by HRP (46 nM) 
and H2O2 (200 µM) was performed at pH 8.1 in buffer (0.2 M Tris-HCl, 
1 mM EDTA) containing 10% DMSO. HRP (40 µL of 1.14 µM solution) 
and H2O2 (20 µL of 10 mM solution) were pre-incubated for 5 min 
then added to the solution of the compounds (940 µL). The solution 
was immediately transferred to a cuvette and the UV-Visible 
spectrum was recorded between 250 and 600 nm every 30 s on a 
Cary 50 spectrometer (Varian, Palo Alto, CA, USA). Rate constants kobs 
were calculated, with Kaleidagraph software, by fitting OD324nm (Oc-
OH-Tam), OD413nm (Fc-OH-Tam), OD418nm (Rc-OH-Tam) and OD279nm 
(OH-Tam[3]) versus time data according to the first order law 
equation : OD = C0 + C1 x exp(-kobs x t). 
Enzymatic activity estimation of isolated TrxR1 and TrxR2 
Highly purified cytosolic (TrxR1) and mitochondrial (TrxR2) 
thioredoxin reductase were prepared from rat liver according to 
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Luthman and Holmgren17 and to Rigobello and Bindoli,18 
respectively. The protein content of purified enzyme preparations 
was measured according to Lowry et al.19 Thioredoxin reductase 
activity was determined by estimating the DTNB-reducing property 
of the enzymes in the presence of NADPH. Aliquots of highly purified 
TrxR1 or TrxR2 in 0.2 M Tris-HCl buffer (pH 8.1), 1 mM EDTA and 0.25 
mM NADPH were pre-incubated for 5 min with the various 
compounds. Afterward, the reaction was initiated with 1 mM DTNB 
and monitored spectrophotometrically at 412 nm for about 10 min. 
For the oxidized metallocifens derivatives formation, freshly 
prepared compounds at increasing concentrations were incubated 
for 15 min in 0.2 M Tris-HCl buffer (pH 8.1) containing 1 mM EDTA, 
with 0.1 mM H2O2 and 22 nM HRP. Then, TrxR aliquot and 0.25 mM 
NADPH were added and incubated for 5 min. Finally, the reaction was 
initiated with 1 mM DTNB and monitored spectrophotometrically at 
412 nm for about 10 min. 
BIAM assay 
First, TLMs and organic tamoxifen were treated with the mixture of 
22 nM HRP/0.1 mM H2O2 for 15 min as reported in the previous 
paragraph. Then, 1 μM TrxR pre-reduced in the presence 60 μM 
NADPH, was incubated with 2 μM of the obtained derivatives for 30 
min at room temperature, in 50 mM Tris-HCl buffer (pH 7.4) 
containing 200 μM NADPH and 1 mM EDTA. After incubation, 8 μL of 
the reaction mixture was added to 8 µL of 100 μM biotinylated 
iodoacetamide (BIAM) in 0.1 M Tris-HCl at pH 8.5 or in 0.1 M Hepes-
Tris pH 6.0.20 Samples were incubated at room temperature for an 
additional 30 min to allow BIAM alkylation of free -SH/SeH groups of 
the enzyme. Then, BIAM-modified enzyme was subjected to sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) on 
a 10% gel, and transferred to a nitrocellulose membrane. BIAM 
labelled enzyme was detected with horseradish peroxidase-
conjugated streptavidin and enhanced chemiluminescence 
detection. 
Determination of total thioredoxin reductase activity in Jurkat cell 
lysates  
The human leukemic lymphoblastoid Jurkat cells were cultured in 
RPMI 1640 medium supplemented with 2 mM L-glutamine, 10% FBS 
and 1% penicillin/streptomycin (Invitrogen), at 37 °C in a humidified 
atmosphere of 95% air and 5% CO2. Cells (2 x 106) were incubated 
with 15 μM compounds for 18 h, then harvested and washed with 
PBS. Each sample was lysed with a modified RIPA buffer: 150 mM 
NaCl, 50 mM Tris-HCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, 0.5% 
DOC, 1 mM NaF and an antiprotease cocktail (“Complete” Roche, 
Mannheim, Germany) containing 0.1 mM PMSF. After 40 min at 4 °C, 
lysates were centrifuged at 12000g for 6 min. The supernatants were 
tested for total TrxR activity. Therefore, aliquots of lysates (12 μg 
proteins) were incubated for 40 min in a final volume of 50 μL in 100 
mM Hepes-Tris buffer (pH 7.6), in the presence of 15 mM EDTA, 1.5 
mM NADPH, 0.20 mM insulin, and 100 μM Trx from E. coli. The 
reaction was stopped by the addition of 0.2 mL of 1 mM DTNB in 0.2 
M Tris-HCl buffer (pH 8.1) containing 1 mM EDTA and 7.2 M 
guanidine, and samples O.D. was estimated at 412 nm21 on a plate 
reader (Tecan Infinite® M200 PRO, Männedorf, CH). 
Preparation of cytosol and mitochondria enriched fractions and 
evaluation of thioredoxin reductase activity 
To obtain cytosolic and mitochondrial fractions, Jurkat cells (3 x 107) 
were grown in 75 cm2 flasks and then treated with the various 
compounds (30 µM) for 18 h. After incubation, cells were processed 
to obtain mitochondria and cytosol enriched fractions essentially 
following the protocol of Clayton and Shadel.22 Briefly, cells were 
collected, washed with PBS and subjected to hypo-osmotic 
treatment with 2 mL of 10 mM NaCl, 1.5 mM MgCl2 and 10 mM Tris-
HCl (pH 7.5) for 5 min and gently homogenized using a Dounce tissue 
grinder. After this treatment, 1.4 mL of 525 mM mannitol, 175 mM 
sucrose, 12.5 mM Tris-HCl (pH 7.5) with 2.5 mM EDTA (pH 7.5) were 
rapidly added. Then, the homogenate was diluted to a final volume 
of 5 mL with 210 mM mannitol, 70 mM sucrose, 5 mM Tris-HCl (pH 
7.5) buffer, 1 mM EDTA (pH 7.5) and subjected to differential 
centrifugation. The first step was carried out at 1300g for 5 min at 4 
°C to discard nuclei and non-disrupted cells. The mitochondrial 
enriched fraction was pulled down from the supernatant at 15800g 
for 15 min at 4 °C and washed twice. The crude soluble supernatant 
obtained from the mitochondrial isolation step, was further 
centrifuged at 105000g for 15 min in order to obtain the cytosolic 
fraction. Afterward, mitochondrial samples were lysed using a 
modified RIPA buffer, as reported in the previous paragraph, and 
subjected to protein determination with the Lowry assay.19 In 
addition, the presence of cytochrome oxidase as a mitochondrial 
marker was assessed by Western blot analysis, using an anti-
cytochrome c oxidase subunit 4 monoclonal antibody 1D6. Both 
cytosolic and mitochondrial fractions (50 µg of proteins) were then 
tested for thioredoxin reductases activity, in a buffer containing 0.2 
M NaKPi, 5 mM EDTA (pH 7.4) with 20 mM DTNB. After 2 min, 0.25 
mM NADPH was added and the reaction was followed at 412 nm at 
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25 °C using a Lambda 2 spectrophotometer (PerkinElmer, Waltham, 
MA, USA).  
Redox Western Blot Analysis of Trx2  
The redox state of Trx was detected using a modified Western blot 
analysis.23,24 Briefly, after treatment with the compounds (15 μM) for 
18 h, Jurkat cells (2 x 106) were washed with PBS and lysed in 100 μL 
of urea lysis buffer (100 mM Tris-HCl, pH 8.3, containing 1 mM EDTA, 
8 M urea, and 10 mM IAM) in order to alkylate free thiols. Incubation 
was carried out at 37 °C for 20 min. Then, cell lysates were spun down 
and precipitated by ice-cold acetone-1 M HCl (98:2). The pellets were 
washed twice with ice-cold acetone-1 M HCl-H2O (98:2:10) and re-
suspended in 60 μL of urea lysis buffer including 3.5 mM DTT and 
incubated for 30 min at 37 °C to reduce the disulfide bonds. 
Afterward, 3 μL of 600 mM IAM (final concentration 30 mM) were 
added to the samples, followed by incubation for 30 min at 37 °C. 
Protein concentration was determined by the Lowry assay.19 Proteins 
were separated by urea-PAGE (7% acrylamide/bis(acrylamide) in 7 M 
urea) and blotted on a nitrocellulose membrane using Trans-Blot® 
TurboTM System (Bio-Rad Laboratories, Hercules, CA, USA). 
Membranes were probed with the primary antibody for Trx2 (H75). 
Flow cytometric analysis of the mitochondrial membrane potential 
and superoxide production in Jurkat cells 
Drug-influenced cell mitochondrial membrane potential was 
analyzed by flow cytometry with the fluorescent probe tetramethyl 
rhodamine methyl ester (TMRM). Jurkat cells (2 x 106) were treated 
for 18 h with the compounds (15 µM) and then harvested and re-
suspended in PBS/10 mM glucose/25 nM TMRM (final 
concentration) for 15 min at 37 °C in the dark. Induced changes of 
membrane potential were estimated with a FACSCanto™ II flow 
cytometer (Becton-Dickinson, CA, USA) using an argon laser at 585 
nm. Cell cultured and treated in the same conditions described 
above, were also probed for mitochondrial superoxide production 
utilizing the fluorescent probe MitoSOX™ Red. After treatment with 
the complexes, Jurkat cells (5 x 105) were incubated with 1 µM 
MitoSOX™ in PBS/10mM glucose for 25 min in the dark, then diluted 
(1:4) and analyzed on FACSCanto™ using an argon laser at 585 nm.  
Determination of short-term cellular ROS production in Jurkat cells  
Jurkat cells (4 x 105 per well) were seeded in a 96 well plate in PBS/10 
mM glucose and then incubated for 1 h with 15 µM 
dihydrorhodamine 123 (DHR) at 37 °C, 5% CO2. Afterwards, the 
medium was removed and each well was added with 100 µM PBS/10 
mM glucose supplemented with 10 µM TLMs or organic tamoxifen 
derivatives. Finally, ROS production was estimated monitoring the 
fluorescence increase of the probe (λEx= 500 nm, λEm= 536 nm), using 
a Tecan Infinite® M200 PRO plate reader. 
Estimation of cytochrome c release and caspase-3 activation  
Cytochrome c release and caspase-3 activation were detected by 
Western blot technique. After 18 h of incubation in presence of 15 
µM of the compounds, Jurkat cells (2 x 106) were harvested, washed 
with PBS, and treated with a hypotonic lysis buffer (20 mM Hepes-
Tris buffer (pH 7.5), 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA and 1 
mM EGTA) added with an antiprotease cocktail (Complete, Roche, 
Mannheim, DE) for 15 min. Then, the suspension was centrifuged at 
12500g for 10 min at 4 °C. The supernatant added with 0.5 mM EGTA 
and 2.5 mM PMSF, was centrifuged for 30 min at 100000g at 4 °C to 
obtain the cytosolic fraction. The pellet obtained from the first 
centrifugation was lysed in the previously reported modified RIPA 
buffer. Aliquots of 10 µg protein of the supernatants or of the pellets 
were subjected to SDS-PAGE (15%) followed by Western blot using a 
cytochrome c monoclonal antibody clone 7H8.C12 and a caspase-3 
polyclonal antibody clone H-277. A peroxidase-conjugated 
secondary antibody and chemiluminescence were used to detect the 
immunoreactive bands. 
Metal quantification in Jurkat cell compartments by ICP-OES  
Jurkat cells (3 x 107 cells) incubated for 18 h in the presence of the 
compounds (30 μM) were subjected to cell fractionation as reported 
in a previous paragraph. For ICP-OES experiments, mitochondria and 
crude nuclei fractions were dissolved in 0.54 mL HCl (37%, Fluka for 
trace analysis) and digested at 60 °C in an ultrasound bath for 1 h. 
Then the samples volume was brought to 10 mL by addition of water 
([HCl] in the sample = 2%). The cytosol samples were adjusted to 2% 
HCl by addition of proper volumes of 37% HCl and water (final 
volume = 10 mL). All the solutions were filtered on a 0.45 μm syringe 
filter. Quantification of iron, ruthenium and osmium was performed 
at 238.204, 267.876 and 225.585 nm, respectively using an Agilent 
5100 instrument (Santa Clara, CA, USA). Metal standards (Fe, Ru and 
Os) were prepared from 1000 ppm stock solutions. The 
concentrations used for calibration were in all cases 0, 7.8, 15.6, 31.2, 
62.5, 125, 250 and 500 ppb. Measurements were done in triplicate 
in two or three sets of independent experiments. HCl was used 
instead of HNO3 as the latter leads to the formation of the highly 
toxic and volatile OsO4. ICP-OES experiments were performed on the 
ALIPP6 platform at University Pierre et Marie Curie, Paris on a Agilent 
5100 instrument. 
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Statistical analysis 
All the experiments reported, if not indicated, are the mean with 
respective SD of, at least, 4 experiments. The statistical analysis of 
variance (ANOVA) was performed using Tukey test with INSTAT 3.3 
(GraphPad) software. 
 
Results 
Synthesis 
TLMs of the group-8 metals Fc-OH-Tam, Rc-OH-Tam and Oc-OH-Tam 
(Chart 1) used in this study were prepared following previously 
reported protocols and are stable for months in the solid state.3,15,25 
TLMs are obtained as a mixture of Z and E stereomers. We previously 
found that these stereomers rapidly isomerize in protic medium. 
Thus the experiments reported herein were performed with 
mixtures of (Z+E) isomers of the 3 complexes. The biochemical 
behaviour of the TLMs was systematically compared to that of 3 
analogous organic tamoxifens, namely Tam, its active metabolite 
OH-Tam[2] and OH-Tam[3], the organic analogue including the same 
dimethylamino-terminated side chain as in the three TLMs which 
was prepared according to the literature.26 
Identification of the products of enzymatic oxidation by HRP/H2O2 
mixture 
Enzymatic oxidation of TLMs and their organic counterparts by the 
HRP/H2O2 mixture was monitored by UV-visible spectrometry. For 
Fc-OH-Tam, progressive appearance of an intense band at 402 nm 
was observed which was readily assigned to the quinone methide by 
comparison with the authentic product obtained by chemical 
oxidation with Ag2O (Fig. S1-A).7,27 This conversion corresponds to a 
2-electrons, 2-protons abstraction pathway. The same behaviour 
was found for Rc-OH-Tam for which a band at 418 nm was observed 
upon oxidation with HRP/H2O2 (Fig. S1-B). In contrast, enzymatic 
oxidation of OH-Tam[3] led to the rapid disappearance of its 
characteristic band at 279 nm but no new peak appeared on the 
spectra (Fig. S1-C). Thus, treatment of OH-Tam[3] by HRP/H2O2 did 
not afford the quinone methide which is characterized by an intense 
band around 400 nm.28 Previous literature data demonstrated that 
HRP oxidation of OH-Tam[2] rather affords unstable radical species 
that tend to polymerize.29 We previously found that enzymatic 
oxidation of Oc-OH-Tam did not afford a quinone methide as did 
chemical oxidation with AgO2 but rather led to a quinone methide 
carbocation characterized by a band at 331 nm resulting from a two-
electrons, 1-proton abstraction pathway.16 This unusual behaviour 
was assumed to originate from the high stability of carbenium ions 
derived from osmocene derivatives.30,31 Table 1 summarizes the 
oxidation pathway of the compounds under study and the rate 
constants of oxidation upon treatment with HRP/H2O2. As it appears, 
oxidation of all the compounds proceeded swiftly, with a slightly 
faster rate observed for ferrocifen than for ruthenocifen and 
osmocifen. 
Table 1. Summary of enzymatic oxidation experiments 
Compound Oxidation 
pathway 
λ max 
(nm) 
Nature of oxidation 
product 
Rate constant of 
oxidation (min-1) 
Fc-OH-Tam -2e-/-2H a) 402 QM 0.521± 0.022 d) 
Rc-OH-Tam -2e-/-2H 418 QM 0.319 ± 0.008 d) 
Oc-OH-Tam -2e-/-1H b) 331 QM+ 0.305 ± 0.002 d) 
OH-Tam[3] -1e-/-1H c) none n.d. 0.471 ± 0.02 e) 
a) data from ref 8; b) data from ref 16; c) data from ref 29; d) rate 
constant of QM or QM+ formation; e) rate constant of substrate 
disappearance 
In vitro inhibition studies on TrxR1 and TrxR2 
The possible inhibitory activity of the three TLMs and the three 
organic analogues was first investigated on TrxR1 and TrxR2 purified 
from rat liver. Experimentally, mixtures of pre-reduced TrxR1 or 
TrxR2 and various concentrations of each compound were incubated 
for 5 min before their enzymatic activity was measured. Table 2 
gathers the IC50 values deduced from these experiments.  
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Table 2. In vitro inhibitory effect of tamoxifen-like metallocifens and organic tamoxifen derivatives on cytosolic (TrxR1) and mitochondrial 
(TrxR2) thioredoxin reductase 
 IC50 (µM) a) IC50 (µM)  
after treatment with H2O2/HRP b) 
Compound TrxR1 TrxR2 TrxR1 TrxR2 
Fc-OH-Tam 15 ± 2 c) 32 ± 3 0.06 ± 0.02 10.9 ± 1.2 
Rc-OH-Tam 62 ± 2 > 100 0.42 ± 0.08 4.6 ± 0.1 
Oc-OH-Tam 40 ± 3.5 23 ± 3 1.2 ± 0.1 d) 3.9 ± 0.1 
Tam > 100 > 100 > 10 > 10 
OH-Tam[2] > 100 > 100 8.7 ± 1.1 > 10 
OH-Tam[3] > 100 > 100 8.1 ± 0.8 > 10 
a) Compounds were incubated with TrxR1 or TrxR2 in the presence of NADPH. After 5 min, TrxR activity was estimated as described in 
Experimental section; b) Compounds were incubated in 0.2 M Tris-HCl buffer (pH 8.1) containing 1 mM EDTA, with 22 nM HRP and 0.1 mM 
H2O2 for 15 min at 25 °C. The mixture was then incubated with TrxR1 or TrxR2 as indicated in a); c) value from ref 8; d) value from ref 16 
Both Fc-OH-Tam and Oc-OH-Tam were moderate inhibitors of both 
TrxR1 and TrxR2 with IC50 between 15 and 23 µM, while Rc-OH-Tam 
was slightly active on TrxR1 and inactive on TrxR2. In contrast, none 
of the organic counterparts were active on both TrxR1 and TrxR2. 
Strikingly different results were obtained when the TLMs were 
enzymatically oxidized by a mixture of HRP and H2O2 for 15 min prior 
to incubation with TrxR. Indeed, all three TLMs became potent 
inhibitors of TrxR1 with a remarkably low IC50 of 60 nM for the iron 
complex, followed by an IC50 of 0.42 µM for the ruthenium complex 
and 1.2 µM for the osmium complex. It is also interesting to notice 
that oxidized Fc-OH-Tam was significantly more active on TrxR1 than 
on TrxR2. Conversely, preliminary treatment of OH-Tam[2] and OH-
Tam[3] by HRP/H2O2 led to moderate inhibition of only TrxR1 (IC50 of 
ca. 8 µM) while HRP-treated Tam remained inactive on both TrxRs.  
Metallocifens interaction with the selenocysteine residue of TrxR 
The C-terminal redox active site of TrxR is formed by a Cys-Sec motif 
(Sec = selenocysteine) which is the target of many electrophiles that 
inhibit TrxR by alkylation of Cys and/or Sec residues. 
Fig. 1. BIAM assay after treatment of TrxR1 treated with compounds oxidized by HRP/H2O2 
TLMs and Tam derivatives (2 µM) were treated with HRP/H2O2 for 15 min. The oxidized derivatives obtained (Ox-Mc with Mc =Fc, Oc, Rc; Ox-
OH-Tam[2], Ox-Tam) were incubated in the presence of a pre-reduced aliquot of TrxR1, as reported in Experimental section. Then, aliquots 
of the reaction mixture were added to 50 μM biotinylated iodoacetamide (BIAM) in either buffer at pH 6.0 (0.1 M Hepes-Tris) or pH 8.5 (0.1 
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M Tris-HCl) to alkylate the -SH/-SeH remaining groups. Proteins were transferred to a nitrocellulose membrane, and BIAM conjugated enzyme 
was detected with streptavidin-horseradish peroxidase conjugate. a, a′: None; b, b′: Cnt; c, c′: Ox-Tam; d, d′: Ox-OH-Tam[2]; e, e′: Ox-Fc; f, 
f’: Ox-Oc; g, g′: Ox-Rc.  
Discrimination between both residues can be achieved by carrying 
out the biotin-iodoacetamide (BIAM) assay. The pKa of both residues 
being different (pKa R-SeH/R-Se- = 5.24; pKa R-SH/R-S-= 8), selective 
alkylation by BIAM can be achieved according to the pH. At low pH 
(6), only the selenolate group of Sec is alkylated by BIAM while at 
high pH (8.5), both the thiolate and the selenolate groups of Cys and 
Sec are simultaneously alkylated by BIAM.32 Mixtures of TrxR1 and 
oxidized TLMs or organic tamoxifens were allowed to react with 
BIAM at pH 6 or 8.5 to alkylate the remaining selenolate and/or 
thiolate groups and the samples were submitted to Western blot 
analysis (Fig. 1). Very weak bands were observed for TrxR1 samples 
exposed to the oxidized TLMs then to BIAM at pH 6 while the organic 
analogues had no effect. In consequence, the three oxidized TLMs 
equally interacted with Sec by probable alkylation of the highly 
nucleophilic selenolate group. When alkylation by BIAM was carried 
out at pH 8.5, the TrxR1 sample exposed to Oc-OH-Tam gave a band 
weaker than the control, indicating that only oxidized Oc-OH-Tam 
was able to simultaneously alkylate thiol groups. In addition, the 
HRP/H2O2 mixture alone had no effect on the ability of BIAM to 
alkylate TrxR1 (cnt, lane b and b′). 
Activities of cytosolic and mitochondrial thioredoxin reductases in 
Jurkat cells 
Jurkat cells (2 x 106) were incubated with each compound (15 µM) 
for 18 h. Then the activity of total TrxR was determined in cell lysates 
(Fig. S2). A large decrease of total TrxR activity (60 to 95% inhibition) 
was observed in cells treated with the three TLMs while Tam and OH-
Tam[2] induced a slight increase of activity and OH-Tam[3] had no 
effect. Additional experiments with Fc-OH-Tam showed that the 
activity of total TrxR was time-dependent as a slight increase was 
observed after 3 h followed by progressive and slow inhibition in the 
next 15 h (Fig. S3). After optimization of the ratio between 
compounds (30 µM) and cell number (3 x 107), the activity of TrxR1 
and TrxR2 was measured separately in the cytosolic and 
mitochondrial fractions of Jurkat cells (Fig. 2). High inhibition of TrxR2 
was found for cells exposed to Fc-OH-Tam and Rc-OH-Tam (72% and 
79.4% inhibition, respectively), while Oc-OH-Tam was less effective 
(44% inhibition). However, organic tamoxifens were significantly less 
potent (up to 27% inhibition). In contrast the effect of the three TLMs 
on TrxR1 was less pronounced (25- 36 % inhibition) and not much 
different from that of the organic compounds (12-21 % inhibition). 
 
Fig. 2. TrxR1 and TrxR2 activities in Jurkat cells. Cytosolic and 
mitochondrial fractions were isolated from Jurkat cells treated with 
the different compounds (30 µM/ 3 x 107 cells for 18 h), and TrxRs 
activities were estimated as reported in Experimental Section. *: p 
<0.05; **: p<0.01; ***: p< 0.001. 
 
Mitochondrial thioredoxin (Trx2) redox state in Jurkat cells 
As all three TLMs and not the organic analogues induced strong 
inhibition of TrxR2 in Jurkat cells, the redox state of Trx2 in cells 
exposed to each compound at 15 µM for 18 h was evaluated by the 
protein electrophoretic mobility shift assay with iodoacetamide / 
iodoacetic acid (IAM/IAA) as follows.33 Lysates of cells incubated with 
each compound were first treated with IAM to titrate free SH groups, 
then, after reaction with DTT to reduce disulphide bonds, IAA was 
added in order to derivatize the SH groups arising from previously 
oxidized cysteines. Samples were submitted to urea-PAGE in non-
reducing conditions and the 3 states of Trx2 (fully oxidized, partially 
oxidized and fully reduced) were detected by Western blot analysis 
(Fig. 3). 
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Fig. 3. Redox state of mitochondrial thioredoxin (Trx2) in Jurkat 
cells. Jurkat cells incubated for 18 h with 15 µM TLMs or organic 
tamoxifens were lysed and lysates treated with 10 mM IAM/IAA 
procedure to titrate reduced, partially oxidized and fully oxidized 
thiol groups. Redox state of Trx2 was then detected by Western Blot 
analysis (A). a: Cnt; b: Tam; c: OH-Tam[2]; d: OH-Tam[3]; e: Fc-OH-
Tam; f: Oc-OH-Tam; g: Rc-OH-Tam. (B) Densitometric analysis of the 
lanes performed with ImageJ software. 
Cells incubated with the 3 TLMs showed accumulation of the fully 
oxidized form of Trx2, especially those exposed to Fc-OH-Tam (90%) 
and to a lesser extent those exposed to the Rc-OH-Tam and Oc-OH-
Tam (57%). Conversely, the fully reduced form of Trx2 was 
predominant in cells exposed to Tam and OH-Tam[2] (77%). Only 
OH-Tam[3] induced the accumulation of a significant amount of 
oxidized forms of Trx2 (ca. 50%). 
ROS production and evaluation of the mitochondrial membrane 
potential (MMP) in Jurkat cells 
Short term (0-30 min) mitochondrial ROS production in Jurkat cells 
was first measured using the DHR dye, after cell incubation with 10 
µM of TLMs or organic tamoxifens. We found that TLMs, but not the 
organic compounds increased the basal ROS production during this 
period (Fig. S4). Long term mitochondrial superoxide level was then 
evaluated in Jurkat cells incubated with 15 µM TLMs or organic 
tamoxifens after 18 h, by flow cytometry analysis using MitoSOX™ 
Red as fluorescent probe (Fig. 4 left). A very high percentage of cells 
(72%) incubated with Fc-OH-Tam emitted high MitoSOX™ 
fluorescence. This percentage was lower for cells incubated with Rc-
OH-Tam and Oc-OH-Tam (around 40%) while the percentage of cells 
emitting high MitoSOX™ fluorescence was insignificant for those 
incubated with the organic tamoxifens (6-8 %). The mitochondrial 
membrane potential (MMP) was evaluated on the same pool of cells 
by flow cytometry using the fluorescent dye TMRM (Fig. 4 right). The 
population of cells with low MMP was close to 100% for cells 
incubated with the three TLMs for 18 h while the three organic 
tamoxifens affected the MMP to a much lower extent (up to 37.5% 
for OH-Tam[3]. Interestingly, the rate of depolarization of the 
mitochondrial membrane was fast for Fc-OH-Tam since the 
percentage of cells displaying low MMP was already equal to 42% 
after 3 h (Fig. S5). 
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Fig. 4. Effects of TLMs and organic tamoxifens on mitochondrial superoxide production (left) and membrane potential (right) in Jurkat 
cells.  
Cells were treated for 18 h with the various compounds (15 μM). Then, aliquots of cells were incubated in PBS/10 mM glucose in the presence 
of 1 µM MitoSOX for the determination of superoxide production, or 25 nM TMRM for the measurement of MMP. Fluorescence was detected 
using a flow cytometric analysis. The left panel reports quantification of superoxide production (red bars). The right panel shows the MMP 
analysis in Jurkat cells where dark blue corresponds to cell population with low membrane potential, while light gray is related to cell 
population with high membrane potential.
  
Activation of the apoptotic pathway 
Release of cytochrome c and state of caspase 3 were examined in 
Jurkat cells exposed to the three TLMs or the organic tamoxifens for 
18 h (Fig. 5).  
 
Fig. 5. Apoptosis pathway activation in Jurkat cells incubated with 
TLMs or tamoxifens derivatives. Jurkat cells (2 x 106) were treated 
for 18 h in the presence of 15 µM compounds. Cytochrome c 
localization was evaluated in cytosol (A) and in mitochondria (B); pro-
caspase-3 detection is reported in (C). a: Cnt; b: Tam; c: OH-Tam[2]; 
d: OH Tam[3]; e: Fc-OH-Tam; f: Oc-OH-Tam; g: Rc-OH-Tam  
 
The results clearly show that after incubation with the three TLMs, 
cytochrome c was released from mitochondria to cytosol while it was 
still located in mitochondria for cells treated with organic 
tamoxifens. Moreover, pro-caspase 3 was only detected in cells 
exposed to organic tamoxifens and not in cells exposed to TLMs. Thus 
only TLMs and not organic tamoxifens were able to trigger cell 
apoptosis by the mitochondria-mediated pathway. 
Intracellular distribution of metals in Jurkat cells 
As we found that metallocifens induced mitochondria impairment 
we undertook, by ICP-OES, quantification of iron, ruthenium and 
osmium in mitochondria and cytosol of cells exposed to Fc-OH-Tam, 
Rc-OH-Tam and Oc-OH-Tam (Table 3, Fig. S6). As iron is a metal 
present in cells its quantification was also performed in untreated 
cells.   
Table 3. ICP-OES quantification of iron, ruthenium and osmium in 
cytosol and mitochondria of Jurkat cells incubated for 24h with 30 
µM Fc-OH-Tam, Oc-OH-Tam and Rc-OH-Tam and of iron in untreated 
cells  
 
Compound Cytosol 
(nmol/mg protein) 
Mitochondria 
(nmol/mg protein) 
Fc-OH-Tam a) 10 ± 5 153 ± 43 
Oc-OH-Tam b) 5.5 ± 4.9 108 ± 31 
Rc-OH-Tam c) 0.13d 75 
Untreated cells (Fe) 1.5 ± 0.9 19 ±11 
a) mean of 3 experiments; b) mean of 2 experiments; c) single 
experiment; d) value in the range of the blanks. 
 
The amounts of iron, osmium and ruthenium in the cytosol and in 
mitochondria were in the same order of magnitude, indicating that 
the three TLMs were all able to accumulate in cells with a high 
concentration in the mitochondria. The amount of iron in the cytosol 
and mitochondria of cells incubated with 30 µM Fc-OH-Tam was 
significantly higher than the level of iron in control cells, indicating 
that it mostly originated from Fc-OH-Tam and not from the 
endogenous iron pool.  
Subcellular distribution of the metals gave an almost exclusive 
localization in the nuclear crude fractions (45-54%) and mitochondria 
(37-50%) and only a marginal localization in the cytosol (5-9%) (Table 
4). 
 
Table 4. Subcellular distribution (%) of Fe and Os in Jurkat cells 
incubated with 30 µM Fc-OH-Tam and Oc-OH-Tam for 24 h.  
Compound Cytosolic 
fraction (%) 
Mitochondrial 
fraction (%) 
Crude nuclear 
fraction (%) 
Fc-OH-Tam a) 9 ± 2 37 ± 7 54 ± 9 
Oc-OH-Tam b) 5 ± 2 50 ± 7 45 ± 4 
a) mean of 3 experiments ; b) mean of 2 experiments 
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Lipophilic cations are well known to preferentially localize in 
mitochondria.34,35 At physiological pH, the dimethylamino group of 
TLMs is protonated, thus they can be considered as lipophilic cations. 
Consequently, they are expected to target mitochondria. Such 
behaviour is also encountered for other lipophilic metal-based drug 
candidates of gold(I),36 osmium(II),37 and rhenium(I).38 
Discussion 
In vitro inhibition of TrxR by TLMs occurred after their enzymatic 
oxidation by the HRP/H2O2 mixture and the products of oxidation 
were in general more active on the cytosolic isoform (IC50 in the 0.06 
- 1.2 µM range) than on the mitochondrial form (IC50 in the 3.9 - 10.9 
µM range, Table 1). On the contrary, oxidized organic tamoxifen 
derivatives were much poorer inhibitors of TrxR thus underlining the 
essential role played by the metallocenic entity in the oxidation 
profile and in the inactivation of TrxR. Independent spectroscopic 
studies showed that the species responsible for TrxR inhibition were 
their quinone methides for Fc-OH-Tam and Rc-OH-Tam and the 
quinone methide cation for Oc-OH-Tam, all display a highly 
electrophilic character. The inability of the HRP/H2O2 system to 
generate the QM of organic tamoxifens confirmed this assertion. 
Within the TLMs series, the extent of inhibition depends on both the 
metallocene unit and the TrxR isoform. Oxidized Fc-OH-Tam was 
significantly less efficient on TrxR2 than Rc-OH-Tam and Oc-OH-Tam 
while the reverse was observed for TrxR1 for which oxidized Fc-OH-
Tam was the most active (IC50 = 0.06 µM). This very low value is in 
the range of those measured for gold(I) complexes which are 
recognized as very potent inhibitors of TrxR.14,39-41  
The mechanism of inhibition of TrxR1 by the oxidized TLMs was 
investigated by the BIAM assay. This assay demonstrated that only 
the 3 oxidized TLMs and not the organic tamoxifens interacted with 
the C-terminal redox active site of TrxR1. Oxidized Fc-OH-Tam and 
Rc-OH-Tam selectively interacted with the penultimate 
selenocysteine residue while oxidized Oc-OH-Tam was also able to 
interact with the cysteine residues. The fact that the product of 
oxidation of Oc-OH-Tam is a quinone methide carbocation15 and not 
the neutral quinone methide may provide a rationale for this 
different reactivity. 
A very different behaviour was observed in Jurkat cells, since the 
TLMs themselves were able to inhibit TrxR, indicating that their 
activation occurred in cellulo by endogenous oxidation systems. 
Moreover, all three TLMs were more efficient inhibitors of TrxR2 
compared to TrxR1. This rather puzzling result is easily 
understandable when considering the subcellular distribution of the 
complexes, namely low concentration in cytosol and high 
concentration in mitochondria. Such an inversion of selectivity was 
previously noticed for cationic and lipophilic gold(I) complexes that 
displayed the same ability to preferentially accumulate in 
mitochondria.42 The fact that inhibition of the mitochondrial 
thioredoxin system was coupled with alteration of the MMP, 
overproduction of ROS and translocation of cytochrome c may have 
to do with the recently reported deregulation of the redox state of 
cyclophilin D,34 a mitochondrial enzyme involved in the regulation of 
the mitochondrial permeability transition process.43 On the other 
hand, organic tamoxifens were far less potent TrxR inhibitors than 
metallocifens in cells. This finding is in line with the results on purified 
TrxR and highlights again the essential input of the metallocenic units 
on the biological activity of TLMs. 
Among the three TLMs, Fc-OH-Tam behaved differently from the two 
other ones regarding the redox state of Trx2, as cells incubated with 
Fc-OH-Tam contained 90% of fully oxidized form of Trx2 but only 57% 
for Rc-OH-Tam and Oc-OH-Tam. Fc-OH-Tam also induced a higher 
level of mitochondrial superoxide and an early decrease of MMP. 
These differences may be accountable to the much lower redox 
potential of ferrocene derivatives (+0.4 V for Fc,7 versus +0.8 V for 
ruthenium,44 and +0.6 V for Oc,15 in their analogous 
metallociphenols). Indeed, according to Kovacic, only the 
metallocenes with a redox potential between +0.4 and -0.44 V 
display anticancer activity since this range of potentials is favorable 
for in vivo electron transfer and redox cycling.45 In our series, only Fc-
OH-Tam fulfils this requirement. 
Conclusion 
We showed that TLMs became strong inhibitors of both isoforms of 
TrxR after their enzymatic oxidation with HRP/H2O2. All the oxidized 
TLMs were stronger inhibitors of the cytosolic isoform TrxR1 with Fc-
OH-Tam showing a remarkably low IC50 of 60 nM. In Jurkat cells, 
TLMs preferentially accumulated in mitochondria as compared to 
cytosol. Accordingly, they preferentially inhibited the mitochondrial 
isoform of TrxR and stimulated the oxidation of Trx2, leading to cell 
redox imbalance. 
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The induced permeability of the mitochondrial membrane elicited 
release of cytochrome c and activation of the caspase pathway 
leading to cell apoptosis. This type of death found in Jurkat cells 
differs from that previously found in adherent tumour cells MDA-
MB-231 where senescence was mainly observed. This study uncovers 
for the first time the powerful pro-apoptotic effects of TLMs that 
appear to be responsible for their cytotoxicity in a lymphoblastoid 
cancer cell line and could be relevant for future clinical applications 
in the chemotherapy of resistant tumours. 
 
Abbreviations 
BIAM  biotin iodoacetamide 
DHR  dihydrorhodamine 123 
Fc-OH-Tam  1-[4-[3-(Dimethylamino)propyloxy]phenyl]1-(4-
hydroxyphenyl)-2-ferrocenyl-1-butene; 
HRP  horseradish peroxidase;  
ICP-OES  Inductively Coupled Plasma Optical Emission 
Spectroscopy;  
MMP  mitochondrial membrane potential; 
Oc-OH-Tam  1-[4-[3-(Dimethylamino)propyloxy]phenyl]1-(4-
hydroxyphenyl)-2-osmocenyl-1-butene; 
Rc-OH-Tam  1-[4-[3-(Dimethylamino)propyloxy] phenyl-1-(4-
hydroxyphenyl)-2-ruthenocenyl-1-butene; 
Tam  tamoxifen, [1-[4-[2-(Methylamino)ethoxy]phenyl]-
1,2-diphenyl-1-buten-1-yl]yl; 
OH-Tam[2]  4-hydroxy-tamoxifen,(E/Z)-4-[1-[4-[2-(Methylamino) 
ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-phenol; 
OH-Tam[3]  (E/Z)-4-[1-[4-[2-(Methylamino)propyl]phenyl]-2-
phenyl-1-buten-1-yl]-phenol;  
RFU  relative fluorescence unit;  
TLMs  tamoxifen-like metallocifens,  
TMRM  tetramethyl rhodamine methyl ester  
TNBC  triple negative breast cancer;  
TrxR  thioredoxin reductase  
TrxR1  cytosolic thioredoxin reductase  
TrxR2  mitochondrial thioredoxin reductase  
Trx  thioredoxin 
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